Saltar al contenido
Merck
  • Recombinant luteinizing hormone supplementation in women undergoing in vitro fertilization/ intracytoplasmic sperm injection with gonadotropin releasing hormone antagonist protocol: a systematic review and meta-analysis.

Recombinant luteinizing hormone supplementation in women undergoing in vitro fertilization/ intracytoplasmic sperm injection with gonadotropin releasing hormone antagonist protocol: a systematic review and meta-analysis.

Reproductive biology and endocrinology : RB&E (2014-11-26)
Yujing Xiong, Zhiqin Bu, Wei Dai, Meixiang Zhang, Xiao Bao, Yingpu Sun
RESUMEN

The objective of this meta-analysis is to assess the impact of LH supplementation in women undergoing in vitro fertilization/ intracytoplasmic sperm injection (IVF/ICSI) with gonadotropin releasing hormone (GnRH) antagonist protocol. No significant difference in outcomes between LH supplementation and r-FSH alone in women undergoing IVF/ICSI with GnRH antagonist protocol is currently present, and further studies are necessary for more solid conclusions on pregnancy likelihood to be drawn.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Luteinizing hormone releasing hormone, ≥97% (HPLC)
Sigma-Aldrich
Luteinizing hormone releasing hormone salmon, ≥97% (HPLC)